A macro-analysis of 49 different research papers (focusing primarily on animal studies) on the effects of CBD regarding multiple anxiety or stress-oriented disorders, such as Post-Traumatic Stress Disorder, Generalised Anxiety Disorder, and Social Anxiety Disorder to name a few.
Preclinical evidence demonstrates CBD’s efficacy in reducing anxiety behaviours relevant to multiple stress and anxiety based disorders. Early stage human experimental findings support these preclinical results, as well as demonstrating an excellent safety profile.
While more research needs to be carried out, the early stage findings seem promising with regards to using CBD as an anxiolytic agent.
Goodbody has no- association with the organisation that conducted this research and is not in a position to validate the research methods, results or conclusions of the published article. It is provided for awareness of research available that may be of interest only. Any reader should read a range of articles and research to have a balanced and informed view.
